Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians ...

Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

A little more than a century ago a diagnosis of type 1 diabetes was a death sentence. Today, thanks to extraordinary ...

Type 1 diabetes wears many faces—an elusive autoimmune disease, a metabolic mess, a chronic condition that requires lifelong ...

Living with type 1 diabetes today is leaps and bounds easier than it was decades ago. Things are only getting better ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

An international project to create a ‘digital twin’ of the human immune system could help scientists finally tackle grand ...

By Sahil Jahangir Mir In the last decade, doctors and nutrition experts have raised a serious alarm about the growing number of liver diseases among young people, not because of alcohol or infections, ...

Researchers at the University of Surrey are creating immune digital twins to advance personalised medicine and deliver tailored treatments ...

Israel's Betalin Therapeutics is preparing an initial public offering that will value the biotech firm between $150-170 million to fund trials for its diabetes treatment, the company's chief executive ...